| 标题 |
Reassessing the Duration of Induction Therapy for Newly Diagnosed, Transplant‐Eligible Myeloma Patients in the Context of Quadruple CD38 Monoclonal Antibody‐Based Regimens: Is 24 Weeks Optimal? |
| 网址 | |
| DOI | |
| 其它 |
期刊:American Journal of Hematology 作者:Meera Mohan; Sabarinath Radhakrishnan; Carolina Schinke; Eirini Katodritou; Rafeal Fonseca 出版日期:2026 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)